, 37:8 | Cite as

Cross-sectional and longitudinal associations between the active vitamin D metabolite (1,25 dihydroxyvitamin D) and haemoglobin levels in older Australian men: the Concord Health and Ageing in Men Project

  • Vasant HiraniEmail author
  • Robert G Cumming
  • Fiona Blyth
  • Vasi Naganathan
  • David G Le Couteur
  • Louise M Waite
  • David J Handelsman
  • Markus J Seibel


Anaemia and low 25 hydroxyvitamin D (25D) and 1,25 dihydroxyvitamin D (1,25D) levels are common in older people and may adversely affect morbidity and mortality. While there is some evidence for an association between low serum 25D levels and anaemia, there are limited studies among community-dwelling older people. In addition, the relationship between anaemia and the active vitamin D metabolite, 1,25D, has not been investigated. The aim of this study was to examine the associations between serum 25D and 1,25D with anaemia in community-living men aged ≥70 years. Population-based, cross-sectional analysis of the baseline phase and longitudinal analysis of the Concord Health and Ageing in Men Project (CHAMP), a large epidemiological study conducted in Sydney among men aged 70 years and older, were performed; 1666 men were seen at baseline (2005–2007), 1314 men at a 2-year follow-up (2007–2009) and 917 at a 5-year follow-up (2012–2013). The main outcome measurement was haemoglobin levels as a continuous measure. Covariates included 25D and 1,25D, estimated glomerular filtration rate, demographic information, lifestyle measures, health conditions and medication information. The prevalence of anaemia (Hb < 13.0 g/dL, WHO definition) was 14.6 %. In cross-sectional analysis, serum 25D concentrations were positively associated with haemoglobin levels in unadjusted analysis (β value 0.004; 95 % confidence interval (CI) 0.0009, 0.007; p = 0.01), but the associations were no longer significant after multivariate adjustment. The association between 1,25D levels and haemoglobin levels was significant in unadjusted analysis (β value 0.003; 95 % CI 0.002, 0.004; p < 0.0001) and remained significant in adjusted analysis (β value 0.001; 95 % CI 0.004, 0.003; p = 0.01). Serum 1,25D (but not 25D) levels at baseline were significantly associated with changes in haemoglobin over 2 and 5 years in unadjusted (β value 0.002; 95 % CI 0.0009, 0.003; p < 0.0001) and in fully adjusted analyses (β value 0.001; 95 % CI 0.0004, 0.002; p = 0.001). Serum 1,25D, but not 25D, concentrations are independently associated with haemoglobin levels in older men in both cross-sectional and longitudinal analyses. This raises the question whether vitamin D metabolites may influence anaemia states, mediated through different biological pathways, or represent a time-dependent biomarker of chronic ill health.


Vitamin D Calcitriol Anaemia older men Population study 



The CHAMP study is funded by the National Health and Medical Research Council and the Ageing and Alzheimer’s Institute. We thank all the staff working on CHAMP and the participants in the project. VH is funded by the Australian Research Council (ARC) Centre of Excellence in Population Ageing Research (CEPAR).


The views expressed are those of the authors, not of the funders. Data analysis and interpretation were carried out by the authors independently of the funding sources based on the available data. The corresponding author had full access to the survey data.

Conflict of interest


Sponsor’s role

The funding body played no role in the formulation of the design, methods, subject recruitment, data collection, analysis or preparation of this paper.

Author contributions

VH had the idea for the paper, conducted the analyses, interpreted the results and wrote the first draft. All authors contributed to revising the earlier drafts and approved the final paper.


  1. Alon DB, Chaimovitz C, Dvilansky A, Lugassy G, Douvdevani A, Shany S, Nathan I (2002) Novel role of 1,25(OH)(2)D(3) in induction of erythroid progenitor cell proliferation. Exp Hematol 30:403–409CrossRefPubMedGoogle Scholar
  2. Artz AS (2008) Anemia and the frail elderly. Semin Hematol 45(4):261–266CrossRefPubMedGoogle Scholar
  3. Aucella F, Scalzulli RP, Gatta G, Vigilante M, Carella AM, Stallone C (2003) Calcitriol increases burst-forming unit-erythroid proliferation in chronic renal failure, a synergistic effect with r- HuEpo. Nephron Clin Pract 95:c121–c127CrossRefPubMedGoogle Scholar
  4. Bhamra S, Tinker A, Mein G, Ashcroft R, Askham J (2008) The retention of older people in longitudinal studies: a review of the literature. Qual Ageing 9(4):27–35CrossRefGoogle Scholar
  5. Bischoff-Ferrari HA, Borchers M, Gidat F et al (2004) Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 19:265–269CrossRefPubMedGoogle Scholar
  6. Cheng CK, Chan J, Cembrowski GS, van Assendelft OW (2004) Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race. Lab Hematol 10(1):42–53CrossRefPubMedGoogle Scholar
  7. Cumming RG, Handelsman D, Seibel MJ et al (2008) Cohort profile: the Concord Health and Ageing in Men Project (CHAMP). Int J Epidemiol 14Google Scholar
  8. Day RO, Graham GG (2013) Non-steroidal anti-inflammatory drugs (NSAIDs). BMJ, Jun 11;346:f3195. doi:  10.1136/bmj.f3195
  9. Division of Drug Information Service (2011) College of Pharmacy, University of Iowa. IDIS Drug Vocabulary and Thesaurus Description. Available from: Accessed last 19 May 2014
  10. Fliser D (2008) Assessment of renal function in elderly patients. Curr Opin Nephrol Hypertens 17(6):604–608CrossRefPubMedGoogle Scholar
  11. Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156CrossRefPubMedGoogle Scholar
  12. Guillot X, Semerano L, Saidenberg-Kermanac’h N, Falgarone G, Boissier MC (2010) Vitamin D and inflammation. Joint Bone Spine 77:552–557CrossRefPubMedGoogle Scholar
  13. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC (2004) Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104(8):2263–2268CrossRefPubMedGoogle Scholar
  14. Herrmann M, Harwood T, Gaston-Parry O, Kouzios D, Wong T, Lih A, Jimenez M, Janu M, Seibel MJ (2010) A new quantitative LC tandem mass spectrometry assay for serum 25-hydroxy vitamin D. Steroids 75(13–14):1106–1112CrossRefPubMedGoogle Scholar
  15. Hewison M, Burke F, Evans KN et al (2007) Extra-renal 25-hydroxyvitamin D3-1α- hydroxylase in human health and disease. J Steroid Biochem Mol Biol 103(3–5):316–321CrossRefPubMedGoogle Scholar
  16. Hirani V, Naganathan V, Cumming RG, Blyth F, Le Couteur DG, Handelsman DJ, Waite LM, Seibel MJ (2013) Associations between frailty and serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin D concentrations in older Australian men: the Concord Health and Ageing in Men Project. J Gerontol A Biol Sci Med Sci 68(9):1112–1121CrossRefPubMedGoogle Scholar
  17. Holden CA, McLachlan RI, Pitts M et al (2005) Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet 366:218–224CrossRefPubMedGoogle Scholar
  18. Holick MF (2003) Vitamin D, deficiency: what a pain it is. Mayo Clin Proc 78:1457–1459CrossRefPubMedGoogle Scholar
  19. National Kidney Foundation (2002) Kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Available at:
  20. Kiss Z, Ambrus C, Almasi C, Berta K, Deak G et al (2011) Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis. Nephron Clin Pract 117:c373–c378CrossRefPubMedGoogle Scholar
  21. Levey AS, Coresh J, Greene T et al (2005) Expressing the MDRD equation for estimating GFR with IDMS traceable (gold standard ) serum creatinine values. J Am Soc Nephrol 16:69AGoogle Scholar
  22. Liang K, Zeger S (1986) Longitudinal data analysis using generalized linear models. Biometrika 73:13–22CrossRefGoogle Scholar
  23. Lips P (2007) Relative value of 25(OH)D and 1,25(OH)2D measurements. J Bone Miner Res 22(11):1668–1671CrossRefPubMedGoogle Scholar
  24. Lucisano S, Di Mauro E, Montalto G, Cernaro V, Buemi M, Santoro D (2014) Vitamin D and anemia. J Ren Nutr 24(1):61–62CrossRefPubMedGoogle Scholar
  25. Meguro S, Tomita M, Katsuki T, Kato K, Oh H et al (2011) Plasma 25-hydroxyvitamin D is independently associated with hemoglobin concentration in male subjects with type 2 diabetes mellitus. Int J Endocrinol 2011:362981CrossRefPubMedCentralPubMedGoogle Scholar
  26. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J, IOF Committee of Scientific Advisors (CSA) Nutrition Working Group (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20(11):1807–1820CrossRefPubMedGoogle Scholar
  27. Nissenson AR, Goodnough LT, Dubois RW (2003) Anemia: not just an innocent bystander? Arch Intern Med 163:1400–1404CrossRefPubMedGoogle Scholar
  28. Norman AW (2006) Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147:5542–5548CrossRefPubMedGoogle Scholar
  29. Oelzner P, Müller A, Deschner F et al (1997) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 23:193–198Google Scholar
  30. Patel NM, Gutierrez OM, Andress DL, Coyne DW, Levin A et al (2010) Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int 77:715–720CrossRefPubMedGoogle Scholar
  31. Pedersen LB, Nashold FE, Spach KM, Hayes CE (2007) 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res 85:2480–2490CrossRefPubMedGoogle Scholar
  32. Penninx BW, Pahor M, Cesari M, Corsi AM, Woodman RC, Bandinelli S, Guralnik JM, Ferrucci L (2004) Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 52(5):719–724CrossRefPubMedGoogle Scholar
  33. Perlstein TS, Pande R, Berliner N, Vanasse GJ (2011) Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation. Blood 117:2800–2806CrossRefPubMedGoogle Scholar
  34. Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58CrossRefPubMedCentralPubMedGoogle Scholar
  35. Roubenoff R (2003) Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care 6:295–299PubMedGoogle Scholar
  36. Shiekh J, Yesavage J (1986) Geriatric Depression Scale: recent findings and development of a short version. In: Brink T (ed) Clinical gerontology: a guide to assessment and intervention. Howarth Press, New YorkGoogle Scholar
  37. Sim JJ, Lac PT, Liu IL, Meguerditchian SO, Kumar VA et al (2010) Vitamin D deficiency and anemia: a cross-sectional study. Ann Hematol 89:447–452CrossRefPubMedCentralPubMedGoogle Scholar
  38. Slovik DM, Adams JS, Neer RM et al (1981) Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporoticpatients. N Engl J Med 305:372–374CrossRefPubMedGoogle Scholar
  39. Sooragonda B, Bhadada SK, Shah VN, Malhotra P, Ahluwalia J, Sachdeva N (2014) Effect of vitamin D replacement on hemoglobin concentration in subjects with concurrent iron-deficiency anemia and vitamin D deficiency: a randomized, single-blinded, placebo-controlled trial. Acta Haematol 133(1):31–35CrossRefPubMedGoogle Scholar
  40. Ware JE, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233CrossRefPubMedGoogle Scholar
  41. Washburn RA, Smith KW, Jette AM, Janney CA (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46:153–162CrossRefPubMedGoogle Scholar
  42. Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia (2012) Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 196(11):686–687CrossRefGoogle Scholar
  43. World Health Organization (1968) Nutritional anemias: report of a WHO scientific group. WHO technical reports series 405. WHO, GenevaGoogle Scholar
  44. Wu S, Sun J (2011) Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discov Med 11:325–335PubMedCentralPubMedGoogle Scholar
  45. Zittermann A, Jungvogel A, Prokop S, Kuhn J, Dreier J et al (2010) Vitamin D deficiency is an independent predictor of anemia in end-stage heart failure. Clin Res Cardiol 100:781–788CrossRefGoogle Scholar

Copyright information

© American Aging Association 2015

Authors and Affiliations

  • Vasant Hirani
    • 1
    • 2
    • 3
    Email author
  • Robert G Cumming
    • 1
    • 2
    • 3
  • Fiona Blyth
    • 1
  • Vasi Naganathan
    • 1
  • David G Le Couteur
    • 5
    • 6
  • Louise M Waite
    • 1
  • David J Handelsman
    • 5
  • Markus J Seibel
    • 4
    • 7
  1. 1.Centre for Education and Research on Ageing, Concord HospitalUniversity of SydneySydneyAustralia
  2. 2.School of Public HealthUniversity of SydneySydneyAustralia
  3. 3.The ARC Centre of Excellence in Population Ageing ResearchUniversity of SydneySydneyAustralia
  4. 4.Bone Research Program, ANZAC Research InstituteThe University of SydneySydneyAustralia
  5. 5.ANZAC Research InstituteUniversity of SydneySydneyAustralia
  6. 6.Charles Perkins CentreUniversity of SydneySydneyAustralia
  7. 7.Department of Endocrinology & Metabolism, Concord HospitalThe University of SydneySydneyAustralia

Personalised recommendations